What is iRadimed's revenue?

iRadimed (IRMD) generated $86.3M in revenue over the trailing twelve months, up 14.8% year over year.

Is iRadimed profitable?

iRadimed reported $23.6M in net income over the trailing twelve months, a 27.4% net margin.

What are iRadimed's profit margins?

Gross margin is 76.8% and operating margin is 32.4%, with a 27.4% net margin.

What is iRadimed's earnings per share?

iRadimed's diluted EPS over the trailing twelve months is $1.83.

Where does iRadimed's income statement data come from?

Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

iRadimed IRMD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$86.28M+14.8%	$83.81M+14.4%	$80.51M+12.9%	$77.64M+11.7%	$75.15M+11.0%
Total cost of revenue	$19.99M+15.2%	$19.49M+15.4%	$18.46M+13.2%	$17.88M+12.9%	$17.35M+9.4%
Gross profit	$66.3M+14.7%	$64.32M+14.2%	$62.05M+12.8%	$59.75M+11.4%	$57.81M+11.5%
Gross margin	76.8%-0.1pp	76.7%-0.2pp	77.1%-0.1pp	77%-0.2pp	76.9%+0.3pp
Research and development	$3.31M+25.5%	$2.97M+5.0%	$2.75M-5.7%	$2.71M-0.5%	$2.64M-8.7%
Selling and marketing	$17.3M+8.3%	$17.42M+11.6%	$17.33M+20.1%	$16.5M+22.2%	$15.96M+23.1%
General and administrative	$17.74M+7.1%	$17.78M+11.6%	$17.12M+4.8%	$16.73M+4.7%	$16.56M+9.0%
Total operating expenses	$38.34M+9.1%	$38.18M+11.0%	$37.2M+10.5%	$35.94M+11.6%	$35.16M+13.2%
Operating income	$27.95M+23.4%	$26.15M+19.0%	$24.85M+16.6%	$23.81M+11.0%	$22.65M+9.0%
Operating margin	32.4%+2.3pp	31.2%+1.2pp	30.9%+1.0pp	30.7%-0.2pp	30.1%-0.6pp
Other income (expense), net	$2.23M-4.1%	$2.21M-4.2%	$2.06M-10.0%	$2.22M+2.9%	$2.33M+25.5%
Income before income taxes	$30.18M+20.9%	$28.36M+16.8%	$26.91M+14.0%	$26.03M+10.3%	$24.98M+10.4%
Income tax expense	$6.57M+26.6%	$5.88M+16.7%	$5.73M+14.9%	$5.38M+8.4%	$5.19M+10.3%
Net income	$23.61M+19.3%	$22.48M+16.9%	$21.18M+13.7%	$20.66M+10.8%	$19.78M+10.4%
Net margin	27.4%+1.0pp	26.8%+0.6pp	26.3%+0.2pp	26.6%-0.2pp	26.3%-0.2pp
Diluted earnings per share	$1.83+18.1%	$1.75+16.7%	$1.65+13.0%	$1.62+11.0%	$1.55+9.9%
EBITDA	$29.38M+25.4%	$27.31M+19.9%	$25.83M+16.6%	$24.6M+10.5%	$23.43M+8.6%
EBITDA margin	34.1%+2.9pp	32.6%+1.5pp	32.1%+1.0pp	31.7%-0.3pp	31.2%-0.7pp
EBIT	$27.95M+23.4%	$26.15M+19.0%	$24.85M+16.6%	$23.81M+11.0%	$22.65M+9.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about iRadimed.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRadimed's revenue?: iRadimed (IRMD) generated $86.3M in revenue over the trailing twelve months, up 14.8% year over year.
Is iRadimed profitable?: iRadimed reported $23.6M in net income over the trailing twelve months, a 27.4% net margin.
What are iRadimed's profit margins?: Gross margin is 76.8% and operating margin is 32.4%, with a 27.4% net margin.
What is iRadimed's earnings per share?: iRadimed's diluted EPS over the trailing twelve months is $1.83.
Where does iRadimed's income statement data come from?: Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.